Back to Search
Start Over
Sacubitril/valsartan, ivabradine hydrochloride, alirocumab, and evolocumab.
- Source :
-
Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2015 Nov-Dec; Vol. 55 (6), pp. 674-678. - Publication Year :
- 2015
- Subjects :
- Aminobutyrates adverse effects
Anti-Arrhythmia Agents adverse effects
Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents adverse effects
Benzazepines adverse effects
Biphenyl Compounds
Drug Combinations
Humans
Hypoglycemic Agents adverse effects
Ivabradine
Tetrazoles adverse effects
Valsartan
Aminobutyrates therapeutic use
Anti-Arrhythmia Agents therapeutic use
Antibodies, Monoclonal therapeutic use
Anticholesteremic Agents therapeutic use
Benzazepines therapeutic use
Hypoglycemic Agents therapeutic use
Tetrazoles therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1544-3450
- Volume :
- 55
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of the American Pharmacists Association : JAPhA
- Publication Type :
- Academic Journal
- Accession number :
- 26547602
- Full Text :
- https://doi.org/10.1331/JAPhA.2015.15551